京城機電股份(00187.HK):李志豐不再繼續擔任持續督導保薦代表人
格隆匯 11 月 27日丨京城機電股份(00187.HK)發佈公告,公司於近日收到公司持續督導機構中德證券有限責任公司(以下簡稱“中德證券”)的通知。中德證券作為公司2020年非公開發行A股股票的保薦機構和持續督導機構,原指定郝國棟先生和李志豐先生擔任公司持續督導保薦代表人,目前正處於持續督導期。
現由於李志豐先生工作調整,不再繼續擔任公司持續督導保薦代表人。為保證公司持續督導工作的順利進行,中德證券授權繆興旺先生接替李志豐先生擔任公司持續督導的保薦代表人,繼續履行督導工作。本次變更後,公司持續督導保薦代表人為郝國棟先生和繆興旺先生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.